BactiQuant ASOCSE:BACTIQ +3.17%56 Altman Z-Score is 5.80 as of Jun. 30, 2026, which is 20% below its 10-year median of 7.25. GuruFocus rates OCSE:BACTIQ with a GF Score™ of 56/100 and a GF Value™ of kr2.37 (Fairly Valued). The stock has 4 warning signs investors should review. Among 3,005 Industrial Products companies, BactiQuant AS ranks better than 72.81% on this metric.
The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.
Good Sign:
Altman Z-score of 5.63 is strong.
BactiQuant AS has a Altman Z-Score of 5.80, indicating it is in Safe Zones. This implies the Altman Z-Score is strong.
The zones of discrimination were as such:
When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.
The historical rank and industry rank for BactiQuant AS's Altman Z-Score or its related term are showing as below:
OCSE:BACTIQ'
s Altman Z-Score Range Over the Past 10 Years
Min: 1.26 Med: 7.25 Max: 29.87
Current: 5.63
During the past 8 years, BactiQuant AS's highest Altman Z-Score was 29.87. The lowest was 1.26. And the median was 7.25.
BactiQuant AS (OCSE:BACTIQ) Altman Z-Score Explanation
X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.
X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.
X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.
X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.
X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.
Altman Z-Score does not apply to financial companies.
BactiQuant AS Altman Z-Score Related Terms
BactiQuant AS Altman Z-Score Historical Data
* Premium members only.
The historical data trend for BactiQuant AS's Altman Z-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OCSE:BACTIQ vs VLTO, ZWS, CECO: Altman Z-Score Comparison
For the Pollution & Treatment Controls subindustry, BactiQuant AS's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BactiQuant AS Altman Z-Score vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, BactiQuant AS's Altman Z-Score distribution charts can be found below:
* The bar in red indicates where BactiQuant AS's Altman Z-Score falls into.
Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
BactiQuant AS's Altman Z-Score for today is calculated with this formula:
Z
=
1.2
*
X1
+
1.4
*
X2
+
3.3
*
X3
+
0.6
*
X4
+
1.0
*
X5
=
1.2
*
0.6994
+
1.4
*
0.5011
+
3.3
*
-0.4418
+
0.6
*
9.0264
+
1.0
*
0.2964
=
5.80
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.
BactiQuant AS (OCSE:BACTIQ) has a Altman Z-Score of 5.80 as of Jun. 30, 2026. The Altman Z-score measures a company's bankruptcy risk. View historical data on BactiQuant AS and its competitors. This is 20% below median its historical median of 7.25. Over the past decade, BactiQuant AS's Altman Z-Score has ranged from 1.26 to 29.87. According to the industry distribution chart, BactiQuant AS ranks #817 out of 3005 companies in the Industrial Products industry, placing it in the top 27.2%.
Is BactiQuant AS's Altman Z-Score too high?
BactiQuant AS's current Altman Z-Score of 5.80 is 20% below median its 10-year median of 7.25. Over the past 10 years, this metric has ranged from a low of 1.26 to a high of 29.87. The Industrial Products industry median Altman Z-Score is 3.33. BactiQuant AS's value of 5.80 is 74.2% above this industry median. Based on the distribution chart, BactiQuant AS ranks #817 out of 3005 companies in the Industrial Products industry, which is above the industry midpoint. Overall, BactiQuant AS has a GF Score™ of 56/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does BactiQuant AS's Altman Z-Score compare to VLTO and ZWS?
According to the Industrial Products industry distribution chart, BactiQuant AS ranks #817 out of 3005 companies for Altman Z-Score. This puts BactiQuant AS in the upper half of its industry. The industry median Altman Z-Score is 3.33. BactiQuant AS's value of 5.80 is 74.2% above this benchmark. Historically, BactiQuant AS's own Altman Z-Score has ranged from 1.26 to 29.87 over the past decade. While the company's 10-year median is 7.25 vs. the industry median of 3.33, BactiQuant AS has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z-Score for an Industrial Products company?
The median Altman Z-Score among Industrial Products companies is 3.33, based on 3,005 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BactiQuant AS's current Altman Z-Score of 5.80 is 74.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z-Score mean?
A high Altman Z-Score can signal that a stock is expensive relative to its fundamentals. The Altman Z-score measures a company's bankruptcy risk. View historical data on BactiQuant AS and its competitors. For the Industrial Products industry, the median Altman Z-Score is 3.33 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BactiQuant AS's current Altman Z-Score is 5.80, which is 20% below median its own 10-year median of 7.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BactiQuant AS stock overvalued right now?
Based on GuruFocus' analysis, BactiQuant AS (OCSE:BACTIQ) is currently considered Fairly Valued. The stock's GF Value™ is kr2.37, compared to a current price of kr2.60 — trading 9.7% above its estimated fair value. The current Altman Z-Score is 5.80, which is 20% below median its 10-year median of 7.25 and 74.2% above the Industrial Products industry median of 3.33. BactiQuant AS's overall GF Score™ is 56/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z-Score calculated?
Altman Z-Score is calculated from a company's financial statements. For BactiQuant AS (OCSE:BACTIQ), the current Altman Z-Score is 5.80 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BactiQuant AS (OCSE:BACTIQ) Overvalued in 2026?
Based on GuruFocus' analysis, BactiQuant AS stock appears to be overvalued.
The current stock price of kr2.60 is trading 9.7% above its estimated GF Value™ of kr2.37.
GuruFocus considers BactiQuant AS to be Fairly Valued.
Key valuation signals for OCSE:BACTIQ:
Altman Z-Score: 5.80 (20% below median its 10-year median of 7.25)
GF Value™: kr2.37 vs. price of kr2.60 (9.7% above fair value)
Industry Position: 74.2% above the Industrial Products median (#817 of 3005)
No single metric tells the full story. See the OCSE:BACTIQ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BactiQuant AS focuses on delivering technology that ensures optimum usage and handling of water around the world. The company's activities include the development, production, sale and service of BactiQuant Online and BactiQuant Mobile Lab with associated test kits/substrate for the quantification and detection of bacteria in water. Its segments are Aquaculture, Data Centres, Oil & Gas, Water Utility, Industry, and Pharma. The group's products are BQ Online 2.0 PRO, BQ Online, BQ Mobile Lab, and Analysis Kits.
56GF Score
Get the complete analysis for OCSE:BACTIQ
Altman Z-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OCSE:BACTIQ has been successfully added to your 
